CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Hypercholesterolaemia - familial - Management
Basis for recommendation
These recommendations are in line with a guideline published by the National Institute for Health and Clinical Excellence (NICE), Identification and management of familial hypercholesterolaemia [NICE, 2008].
- The recommendation to consider checking blood glucose and renal function is extrapolated from guidelines for people with non-familial dyslipidaemia, including a NICE guideline, Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease [National Collaborating Centre for Primary Care, 2008a]; the Scottish Intercollegiate Guidelines Network (SIGN) guideline Risk estimation and the prevention of cardiovascular disease [SIGN, 2007]; and the Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice [British Cardiac Society et al, 2005].
- The identification of additional risk factors for coronary heart disease will guide the management (in particular, referral) of adults with familial hypercholesterolaemia.
© NHS Institute for Innovation and Improvement